DRDGOLD manager sells 9,029 shares at $2.75
DRDGOLD’s financial manager converted 9,029 deferred share awards into Ordinary Shares and sold the same number in a pooled market transaction.
Rhea-AI Filing Summary
DRDGOLD LTD (DRD) reported that Financial Manager FWGR Ops. Laas Lihan exercised and sold equity-based awards. On August 13, 2026, 9,029 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration under the Single Incentive Plan. A pooled sale then disposed of 9,029 Ordinary Shares on August 31 and September 1, 2026 at an average of $2.7545 (ZAR 44.4764) per share. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Laas Lihan
Role
Financial Manager FWGR Ops.
Sold
9,029 shs ($25K)
Approx. gross sale proceeds
$25K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F2, F3 | 9,029 | $2.7545 | $25K |
| Exercise | Deferred Shares F1, F4 | 9,029 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1 | 9,029 | $0.00 | $0.00 |
Holdings After Transaction:
Deferred Shares — 47,112 contracts (Direct);
Ordinary Shares — 0 shares (Direct)
Footnotes (4)
- F1. On August 13, 2026, 9,029 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
- F2. Represents 9,029 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 9,029 Deferred Shares described in footnote 1.
- F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
- F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.
Key Figures
Ordinary Shares sold: 9,029 shares
Average sale price: $2.7545 per Ordinary Share
Average sale price in ZAR: ZAR 44.4764 per Ordinary Share
+2 more
5 metrics
Ordinary Shares sold
9,029 shares
Pooled sale conducted on August 31 and September 1, 2026
Average sale price
$2.7545 per Ordinary Share
Converted from ZAR using South African Reserve Bank rate on transaction date
Average sale price in ZAR
ZAR 44.4764 per Ordinary Share
Underlying transaction denominated in South African rand
Deferred Shares vested and settled
9,029 shares
Vested on August 13, 2026 and settled one-for-one into Ordinary Shares
Exercise or conversion price
$0.00 per Deferred Share
Deferred Shares settled into Ordinary Shares for no consideration
Key Terms
Deferred Shares, Single Incentive Plan, pooled sale, Ordinary Shares
4 terms
Single Incentive Plan financial
"previously awarded to the Reporting Person under the Company's Single Incentive Plan"
pooled sale financial
"sold on behalf of the Reporting Person as part of a pooled sale conducted"
FAQ
What insider transactions did DRD’s Financial Manager report on this Form 4?
The filing reports that Financial Manager FWGR Ops. Laas Lihan had 9,029 Deferred Shares vest and settle into Ordinary Shares on August 13, 2026, and then sold 9,029 Ordinary Shares in a pooled transaction on August 31 and September 1, 2026.
Were the DRD insider’s trades executed under a Rule 10b5-1 trading plan?
No. The Form 4 indicates no Rule 10b5-1 trading plan; the document-level checkbox is not marked as being pursuant to such a plan, and the footnotes do not state that the transactions were made under a pre-arranged trading arrangement.
AI-generated analysis. How Rhea-AI works. Not financial advice.